iohexol has been researched along with Epithelial Ovarian Cancer in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mingzhu, L | 1 |
| Yaqiong, G | 1 |
| Mengru, L | 1 |
| Wei, W | 1 |
1 other study available for iohexol and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Prediction of BRCA gene mutation status in epithelial ovarian cancer by radiomics models based on 2D and 3D CT images.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Contrast Media; Female; Genes, BRCA1; Genes, BRCA2; Huma | 2021 |